• Eon entered a referral partnership with CancerIQ to help health systems identify high-risk patients earlier, then drive screening completion.
• Deal combines CancerIQ’s risk assessment and patient activation with Eon’s radiology findings identification, follow-up tracking, and longitudinal management.
• Aims to reduce patient leakage before imaging eligibility is recognized, then improve follow-up on incidental findings detected in radiology reports.
• CancerIQ cited a 4.2x lift in supplemental screening, 8.9x average ROI; Eon cited over 90% follow-up completion, up to 12.5x downstream exams.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cancer IQ Inc. published the original content used to generate this news brief on September 15, 2026, and is solely responsible for the information contained therein.